Evidence map›Paper›PMID 25376811›Full record

ArticleAJNR. American journal of neuroradiology2015

Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.

M Cosottini, D Frosini, I Pesaresi, G Donatelli, P Cecchi, M Costagli, L Biagi, R Ceravolo, U Bonuccelli, M Tosetti

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in AJNR. American journal of neuroradiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03022357 (Nigrosomal Iron Imaging in Parkinson's Disease), which is not on this map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03022357 unknown statusnot on this mapstarted 2016, after this paper: background citation

Nigrosomal Iron Imaging in Parkinson's Disease

TypeobservationalSponsorUniversity of NottinghamRan2016 to 2019Enrolled145ConditionsParkinson DiseaseArmsPatient assessment, DATScan, Orbital X-Ray, Magnetic Resonance Imaging (MRI)
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Present and Future of Ultra-High Field MRI in Neurodegenerative Disorders.Current neurology and neuroscience reports · 2018
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Eukaryotic translation initiation factorExperimental and therapeutic medicine · 2024
    Article
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M CosottiniFrom the IMAGO7 Foundation (M. Cosottini, M. Costagli), Pisa, Italy Department of Translational Research and New Technologies in Medicine and Surgery (M. Cosottini, G.D.) mircocosottini@libero.it.
D FrosiniNeurology Unit (D.F., R.C., U.B.), Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
I PesaresiNeuroradiology Unit (I.P., P.C.), Department of Diagnostic and Interventional Radiology, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
G DonatelliDepartment of Translational Research and New Technologies in Medicine and Surgery (M. Cosottini, G.D.).
P CecchiNeuroradiology Unit (I.P., P.C.), Department of Diagnostic and Interventional Radiology, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
M CostagliFrom the IMAGO7 Foundation (M. Cosottini, M. Costagli), Pisa, Italy.
L BiagiStella Maris Scientific Institute (L.B., M.T.), Pisa, Italy.
R CeravoloNeurology Unit (D.F., R.C., U.B.), Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
U BonuccelliNeurology Unit (D.F., R.C., U.B.), Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
M TosettiStella Maris Scientific Institute (L.B., M.T.), Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeStandard neuroimaging fails in defining the anatomy of the substantia nigra and has a marginal role in the diagnosis of Parkinson disease. Recently 7T MR target imaging of the substantia nigra has been useful in diagnosing Parkinson disease. We performed a comparative study to evaluate whether susceptibility-weighted angiography can diagnose Parkinson disease with a 3T scanner. MATERIALS AND

methodsFourteen patients with Parkinson disease and 13 healthy subjects underwent MR imaging examination at 3T and 7T by using susceptibility-weighted angiography. Two expert blinded observers and 1 neuroradiology fellow evaluated the 3T and 7T images of the sample to identify substantia nigra abnormalities indicative of Parkinson disease. Diagnostic accuracy and intra- and interobserver agreement were calculated separately for 3T and 7T acquisitions.

resultsSusceptibility-weighted angiography 7T MR imaging can diagnose Parkinson disease with a mean sensitivity of 93%, specificity of 100%, and diagnostic accuracy of 96%. 3T MR imaging diagnosed Parkinson disease with a mean sensitivity of 79%, specificity of 94%, and diagnostic accuracy of 86%. Intraobserver and interobserver agreement was excellent at 7T. At 3T, intraobserver agreement was excellent for experts, and interobserver agreement ranged between good and excellent. The less expert reader obtained a diagnostic accuracy of 89% at 3T.

conclusionsSusceptibility-weighted angiography images obtained at 3T and 7T differentiate controls from patients with Parkinson disease with a higher diagnostic accuracy at 7T. The capability of 3T in diagnosing Parkinson disease might encourage its use in clinical practice. The use of the more accurate 7T should be supported by a dedicated cost-effectiveness study.

Indexed as

AdultAgedAged, 80 and overCerebral AngiographyFemaleHumansMagnetic Resonance AngiographyMaleMiddle AgedObserver VariationParkinson DiseaseSensitivity and SpecificitySubstantia Nigra

Identifiers

PMID25376811
PMCPMC8013050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.